AMARIN CORP PLC\UK Increase (Decrease) in Prepaid Expense and Other Assets
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $6.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-29
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $4.72M.
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.97M, a 84.34% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$4.80M, a 188.88% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $12.02M.
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for fiscal 2025 was $12.46M, a 1233.62% increase from fiscal 2024.
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for fiscal 2024 was $934.00K.
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$7.87M.
- AMARIN CORP PLC\UK increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.86M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $6.69M 10-Q · filed 2026-07-29 | $1.88M derived: sum of 3 quarters · filed 2026-07-29 | $13.90M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $1.97M 10-Q · filed 2026-04-29 | -$2.83M derived: sum of 2 quarters · filed 2026-04-29 | $9.19M derived: sum of 3 quarters · filed 2026-04-29 | $1.85M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $7.22M derived: sum of 2 quarters · filed 2026-03-02 | -$121.00K derived: sum of 3 quarters · filed 2026-07-29 | $12.46M 10-K · filed 2026-03-02 |
| 2025-09-30 | $12.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $4.68M derived: sum of 2 quarters · filed 2026-07-29 | $17.26M 10-Q · filed 2025-10-29 | $22.66M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$7.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $5.24M 10-Q · filed 2026-07-29 | $10.64M derived: sum of 3 quarters · filed 2026-07-29 | -$13.76M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $12.58M 10-Q · filed 2026-04-29 | $17.98M derived: sum of 2 quarters · filed 2026-04-29 | -$6.42M derived: sum of 3 quarters · filed 2026-04-29 | $16.99M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$19.00M derived: sum of 2 quarters · filed 2026-03-02 | $4.41M derived: sum of 3 quarters · filed 2026-03-02 | $934.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | -$24.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$995.00K derived: sum of 2 quarters · filed 2025-10-29 | -$4.47M 10-Q · filed 2025-10-29 | -$12.32M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $23.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $19.93M 10-Q · filed 2025-07-30 | $12.09M derived: sum of 3 quarters · filed 2026-03-02 | -$11.75M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$3.48M 10-Q · filed 2025-05-07 | -$11.32M derived: sum of 2 quarters · filed 2026-03-02 | -$35.16M derived: sum of 3 quarters · filed 2026-03-02 | -$11.74M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$7.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$31.69M derived: sum of 2 quarters · filed 2026-03-02 | -$8.26M derived: sum of 3 quarters · filed 2026-03-02 | -$7.87M 10-K · filed 2026-03-02 |
| 2023-09-30 | -$23.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$414.00K derived: sum of 2 quarters · filed 2024-10-30 | -$28.00K 10-Q · filed 2024-10-30 | -$8.59M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | $23.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $23.81M 10-Q · filed 2024-07-31 | $15.25M derived: sum of 3 quarters · filed 2025-03-12 | $11.05M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | $386.00K 10-Q · filed 2024-05-01 | -$8.18M derived: sum of 2 quarters · filed 2025-03-12 | -$12.38M derived: sum of 3 quarters · filed 2025-03-12 | -$8.21M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | -$8.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$12.77M derived: sum of 2 quarters · filed 2025-03-12 | -$8.60M derived: sum of 3 quarters · filed 2025-03-12 | -$2.86M 10-K · filed 2025-03-12 |
| 2022-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$34.00K derived: sum of 2 quarters · filed 2023-11-01 | $5.71M 10-Q · filed 2023-11-01 | $6.71M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $9.91M 10-Q · filed 2023-08-02 | $10.91M derived: sum of 3 quarters · filed 2024-02-29 | $3.83M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $5.74M 10-Q · filed 2023-05-03 | $6.75M derived: sum of 2 quarters · filed 2024-02-29 | -$334.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.60M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$6.07M derived: sum of 2 quarters · filed 2024-02-29 | -$7.34M derived: sum of 3 quarters · filed 2024-02-29 | -$8.60M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$7.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$8.35M derived: sum of 2 quarters · filed 2022-10-27 | -$9.60M 10-Q · filed 2022-10-27 | -$4.99M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$2.52M 10-Q · filed 2022-08-03 | $2.09M derived: sum of 3 quarters · filed 2023-03-01 | $4.84M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$1.25M 10-Q · filed 2022-05-04 | $3.36M derived: sum of 2 quarters · filed 2023-03-01 | $6.11M derived: sum of 3 quarters · filed 2023-03-01 | $8.97M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $7.36M derived: sum of 2 quarters · filed 2023-03-01 | $10.22M derived: sum of 3 quarters · filed 2023-03-01 | $17.64M 10-K · filed 2023-03-01 |
| 2020-09-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $5.61M derived: sum of 2 quarters · filed 2021-11-03 | $13.02M 10-Q · filed 2021-11-03 | $13.47M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $10.27M 10-Q · filed 2021-08-05 | $10.72M derived: sum of 3 quarters · filed 2022-03-01 | $16.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $7.42M 10-Q · filed 2021-04-29 | $7.87M derived: sum of 2 quarters · filed 2022-03-01 | $13.62M derived: sum of 3 quarters · filed 2022-03-01 | $15.39M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $452.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.21M derived: sum of 2 quarters · filed 2022-03-01 | $7.98M derived: sum of 3 quarters · filed 2022-03-01 | $10.37M 10-K · filed 2022-03-01 |
| 2019-09-30 | $5.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.53M derived: sum of 2 quarters · filed 2020-11-05 | $9.91M 10-Q · filed 2020-11-05 | $9.92M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $4.16M 10-Q · filed 2020-08-04 | $4.17M derived: sum of 3 quarters · filed 2021-02-25 | $4.22M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.39M 10-Q · filed 2020-04-30 | $2.40M derived: sum of 2 quarters · filed 2021-02-25 | $2.46M derived: sum of 3 quarters · filed 2021-02-25 | $1.72M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $67.00K derived: sum of 2 quarters · filed 2021-02-25 | -$673.00K derived: sum of 3 quarters · filed 2021-02-25 | -$510.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$683.00K derived: sum of 2 quarters · filed 2019-11-05 | -$520.00K 10-Q · filed 2019-11-05 | -$1.25M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$740.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$577.00K 10-Q · filed 2019-07-31 | -$1.31M derived: sum of 3 quarters · filed 2020-02-25 | -$1.70M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $163.00K 10-Q · filed 2019-05-01 | -$567.00K derived: sum of 2 quarters · filed 2020-02-25 | -$958.00K derived: sum of 3 quarters · filed 2020-02-25 | -$3.67M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$730.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$1.12M derived: sum of 2 quarters · filed 2020-02-25 | -$3.83M derived: sum of 3 quarters · filed 2020-02-25 | -$6.03M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$3.10M derived: sum of 2 quarters · filed 2018-11-01 | -$5.30M 10-Q · filed 2018-11-01 | -$4.06M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$4.91M 10-Q · filed 2018-08-01 | -$3.67M derived: sum of 3 quarters · filed 2019-02-27 | -$3.40M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$2.20M 10-Q · filed 2018-05-02 | -$956.00K derived: sum of 2 quarters · filed 2019-02-27 | -$691.00K derived: sum of 3 quarters · filed 2019-02-27 | -$1.32M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.51M derived: sum of 2 quarters · filed 2019-02-27 | $878.00K derived: sum of 3 quarters · filed 2019-02-27 | $3.83M 10-K · filed 2019-02-27 |
| 2016-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$364.00K derived: sum of 2 quarters · filed 2017-11-01 | $2.59M 10-Q · filed 2017-11-01 | $1.05M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$629.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $2.32M 10-Q · filed 2017-08-02 | $787.00K derived: sum of 3 quarters · filed 2018-02-27 | $4.17M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $2.95M 10-Q · filed 2017-05-03 | $1.42M derived: sum of 2 quarters · filed 2018-02-27 | $4.80M derived: sum of 3 quarters · filed 2018-02-27 | $3.81M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.84M derived: sum of 2 quarters · filed 2018-02-27 | $859.00K derived: sum of 3 quarters · filed 2018-02-27 | $519.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.40M derived: sum of 2 quarters · filed 2016-11-03 | $2.06M 10-Q · filed 2016-11-03 | $1.74M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$985.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.32M 10-Q · filed 2016-08-04 | -$1.64M derived: sum of 3 quarters · filed 2017-03-01 | -$1.58M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$340.00K 10-Q · filed 2016-05-05 | -$658.00K derived: sum of 2 quarters · filed 2017-03-01 | -$599.00K derived: sum of 3 quarters · filed 2017-03-01 | -$667.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$259.00K derived: sum of 2 quarters · filed 2017-03-01 | -$327.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.05M 10-K · filed 2017-03-01 |
| 2014-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$9.00K derived: sum of 2 quarters · filed 2015-11-04 | $1.37M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.31M 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $1.38M 10-Q · filed 2015-05-08 | |||
| 2013-12-31 | -$1.69M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |